MayFaek MohamedElbannaMDPhD

PubMed

• 1 citations
  Radiotherapy resources in Latin America and the Caribbean: a review of current and projected needs based on International Atomic Energy Agency data.
  May Elbanna, Yaroslav Pynda, Oleksandr Kalinchuk, Arthur Rosa, May Abdel-Wahab> ;The Lancet. Oncology. 2023 Sep 1
• Cultivating Cultural Humility to Address the Healthcare Burnout Epidemic-Why It Matters.
  Thomas, M., Patel, P., McHenry, M., Elbanna, M.> ;Global Advances in Integrative Medicine and Health. 2023 May 11
• 9 citations
  Clinical and Preclinical Outcomes of Combining Targeted Therapy With Radiotherapy.
  May Elbanna, Nayela N. Chowdhury, R.M. Rhome, Melissa L. Fishel> ;Frontiers in Oncology. 2021 Oct 18
• Impact of Lung Parenchymal-Only Failure on Overall Survival in Early-Stage Lung Cancer Patients Treated With Stereotactic Ablative Radiotherapy.
  May Elbanna, Kevin Shiue, Donna Edwards, Alberto Cerra-Franco, Namita Agrawal, J. Hinton, Todd R. Mereniuk, Christina C. Huang, Joshua L. Ryan, Jessica Smith, Vasantha...> ;Clinical Lung Cancer. 2021 May 1
• Reduced radiation necrosis in radiosurgical treatment of small brain metastases with 22 Gy.
  Todd R. Mereniuk, May Elbanna, Christina C. Huang, Tim Lautenschlaeger, James C Miller, Gordon A. Watson, R.M. Rhome, Shearwood McClelland> ;Journal of Radiosurgery and SBRT. 2021 Jan 1
• 7 citations
  Baseline Karnofsky performance status is independently predictive of death within 30 days of intracranial radiation therapy completion for metastatic disease.
  Namita Agrawal, May Elbanna, Kevin Shiue, G. Bartlett, Tim Lautenschlaeger, Richard C. Zellars, Gordon A. Watson, Susannah G. Ellsworth, Shearwood McClelland> ;Reports of Practical Oncology and Radiotherapy. 2020 Feb 24
• 10 citations
  Dual inhibition of angiopoietin-Tie2 and MET alters the tumor microenvironment and prolongs survival in a metastatic model of renal cell carcinoma
  May Elbanna, Ashley Orillion, Nur P. Damayanti, Remi Adelaiye-Ogala, Li Shen, Kiersten Marie Miles, Sreenivasulu Chintala, Eric Ciamporcero, Swathi Ramakrishnan, Sheng...> ;Molecular Cancer Therapeutics. 2020 Jan 1
• 26 citations
  Antitumor Activity and Mechanistic Characterization of APE1/Ref-1 Inhibitors in Bladder Cancer.
  Melissa L. Fishel, Hanyu Xia, Jack McGeown, David W. McIlwain, May Elbanna, Ariel A. Craft, Hristos Z. Kaimakliotis, George E. Sandusky, Chi Zhang, Roberto Pili, Mark ...> ;Molecular Cancer Therapeutics. 2019 Nov 1
• 59 citations
  Dietary Protein Restriction Reprograms Tumor-Associated Macrophages and Enhances Immunotherapy.
  Ashley Orillion, Nur P. Damayanti, Li Shen, Remi Adelaiye-Ogala, Hayley C. Affronti, May Elbanna, Sreenivasulu Chintala, Michael J. Ciesielski, Luigi Fontana, Chinghai...> ;Clinical Cancer Research. 2018 Dec 15
• 52 citations
  Therapeutic Targeting of TFE3/IRS-1/PI3K/mTOR Axis in Translocation Renal Cell Carcinoma
  Nur P. Damayanti, Justin A. Budka, Heba W.Z. Khella, Mary W. Ferris, Sheng-Yu Ku, Eric C. Kauffman, Anthony C. Wood, Khunsha Ahmed, Venkata Nithinsai Chintala, Remi Ad...> ;Clinical Cancer Research. 2018 Dec 1
• 61 citations
  EZH2 Modifies Sunitinib Resistance in Renal Cell Carcinoma by Kinome Reprogramming
  Remi Adelaiye-Ogala, Justin A. Budka, Nur P. Damayanti, Justine V. Arrington, Mary W. Ferris, Chuan-Chih Hsu, Sreenivasulu Chintala, Ashley Orillion, Kiersten Marie Mi...> ;Cancer Research. 2017 Dec 1
• 28 citations
  Genomic profiling is predictive of response to cisplatin treatment but not to PI3K inhibition in bladder cancer patient-derived xenografts
  Lei Wei, Sreenivasulu Chintala, Eric Ciamporcero, Swathi Ramakrishnan, May Elbanna, Jianmin Wang, Qiang Hu, Sean T. Glenn, Mitsuko Murakami, Lu Liu, Eduardo Cortes Gom...> ;Oncotarget. 2016 Nov 4
• 2 citations
  Alternative approaches to prevent androgen action in prostate cancer: are we there yet?
  May Elbanna, Hannelore V. Heemers> ;Discovery Medicine. 2014 May 1
• Join now to see all